Man Credits Qsymia for helping him lose 50 pounds

FDA-approved drug combines appetite suppressant, anticonvulsant with weight loss side effects

BOCA RATON, Fla. – "I found myself with a blood pressure issue. That's how this all started," said George Miller.

After diets left him feeling hungry and frustrated, Miller saw Dr. Marc Schlosser at Boca Health.

"Most of my patients, by the time they come to see me, they've been through everything," said Schlosser.

Schlosser offered Miller Qsymia, a once-a-day appetite suppressant that the Food and Drug Administration approved as a long-term treatment for obesity. Clinical trials have shown an average of 10 percent weight loss in a year.

Qsymia combines phentermine, an appetite suppressant and topiramate, an anticonvulsant with weight loss side effects.

"My big problem was with craving and snacking in the evening and with Qsymia, it stopped all that," said Miller. "It's so incredibly easy."

Miller lost more than 50 pounds in less than four months.

"As you lose weight, all the metabolic problems, such as high blood pressure, high blood sugar, they all correct as you lose weight," said Schlosser.

The weight loss allowed Miller to drop one of his four blood pressure medications and lower the dosage of three others.

"I actually feel like exercising whereas before I didn't," he said. "It's been a wonderful experience and I'm very happy."

Side effects of Qsymia include constipation, tingling in the fingers, and dry mouth. The drug is offered in four different strengths.

Qsymia costs about $35 a month for those with an insurance co-pay. Those without one can qualify for a program that limits the cost to $75 a month.